Occurrence of Fatal and Nonfatal Adverse Outcomes after Heart Transplantation in Patients with Pretransplant Noncytotoxic HLA Antibodies

Figure 4

Anti-HLA ab and pAMR. Distribution of pAMR grades in patients with and without pretransplant HLA ab.